UnitedHealth leads gainers as chipmakers slip on Oct. 15

UnitedHealth Group (UNH) and Visa (V) led watchlist gainers on Oct. 15, while SpaceX (SPCX), NVIDIA (NVDA) and AMD slipped amid broadly mixed trading.

CompanyClosePrev CloseChange% Change
UNH · UnitedHealth Group Incorporated$406.67$395.62+11.05+2.79%
SPCX · SpaceX$148.62$152.16-3.54-2.33%
V · Visa Inc.$399.75$391.43+8.32+2.13%
NVDA · NVIDIA Corporation$217.23$221.30-4.07-1.84%
AMD · Advanced Micro Devices, Inc.$562.23$570.82-8.59-1.50%
TSLA · Tesla, Inc.$362.44$367.16-4.72-1.29%
MSFT · Microsoft Corporation$539.44$533.69+5.75+1.08%
GOOGL · Alphabet Inc.$349.22$347.64+1.58+0.45%
AAPL · Apple Inc.$342.00$342.96-0.96-0.28%
AMZN · Amazon.com, Inc.$254.76$254.08+0.68+0.27%
META · Meta Platforms, Inc.$736.72$737.54-0.82-0.11%
JPM · JPMorgan Chase & Co.$335.53$335.28+0.25+0.07%

Trading across the watchlist was mixed on October 15, with no stock moving enough to qualify as a sharp swing. UnitedHealth Group (UNH) topped the gainers, while SpaceX (SPCX) posted the largest decline of the session.

Chip and EV names were the session’s softer corner: NVIDIA (NVDA), Advanced Micro Devices (AMD) and Tesla (TSLA) each closed lower, pulling back from their prior session’s closes. Financials and payments names fared better, with Visa (V) and JPMorgan Chase (JPM) both finishing in positive territory alongside UnitedHealth.

Megacap technology was largely muted. Microsoft (MSFT) and Alphabet (GOOGL) edged higher, while Apple (AAPL), Amazon.com (AMZN) and Meta Platforms (META) each closed within a fraction of a percent of their prior-day levels.

Notable movers

UnitedHealth Group (UNH) was the session’s top gainer, closing at $406.67, up from $395.62, a 2.8% advance.

SpaceX (SPCX) led decliners, closing at $148.62 versus a prior close of $152.16, down 2.3%.

Visa (V) closed at $399.75, up from $391.43, a 2.1% gain.

NVIDIA (NVDA) closed at $217.23, down from $221.30, a 1.8% decline.

This content is for informational purposes only and is not investment advice. Always do your own research before making financial decisions.